The fluorescent pentameric oligothiophene pFTAA identifies filamentous tau in live neurons cultured from adult P301S tau mice

Frontiers in Neuroscience

Volumn 9, Issue MAY, 2015, Pages

  Brelstaff, Jack ^a   Ossola, Bernardino ^a   Neher, Jonas J ^b   Klingstedt, Therése ^c   Nilsson, K Peter R ^d   Goedert, Michel ^c   Spillantini, Maria Grazia ^a   Tolkovsky, Aviva M ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

^d LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Alzheimer's disease; Dorsal root ganglion neurons; Fluorescent vital fibrillar tau dye; Frontotemporal dementia (FTD); Hyperphosphorylated tau; Neurofibrillary tangles; Transgenic P301S tau mouse

Indexed keywords

ACETIC ACID; ANTIBODY AT100; ANTIBODY MC1; FORMIC ACID; PENTAMERIC FORMYL THIOPHENE ACETIC ACID; PROTEIN ANTIBODY; TAU PROTEIN; UNCLASSIFIED DRUG;

ADULT; ADULT ANIMAL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY LABELING; ARTICLE; BINDING AFFINITY; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; IMMUNOREACTIVITY; IN VIVO STUDY; MOUSE; NERVE CELL CULTURE; NONHUMAN; PROTEIN AGGREGATION; PROTEIN DETERMINATION; PROTEIN FOLDING; SPINAL GANGLION; TRANSGENIC MOUSE;

EID: 84930625091     PISSN: 16624548     EISSN: 1662453X     Source Type: Journal    
DOI: 10.3389/fnins.2015.00184     Document Type: Article

References (48)

1. Allen, B., Ingram, E., Takao, M., Smith, M. J., Jakes, R., Virdee, K., et al. (2002). Abundant tau filaments and nonapoptotic neurodegeneration in transgenic mice expressing human P301S tau protein. J. Neurosci. 22, 9340-9351.
2. Aslund, A., Sigurdson, C. J., Klingstedt, T., Grathwohl, S., Bolmont, T., Dickstein, D. L., et al. (2009). Novel pentameric thiophene derivatives for in vitro and in vivo optical imaging of a plethora of protein aggregates in cerebral amyloidoses. ACS Chem. Biol. 4, 673-684. doi: 10.1021/cb900112v
3. Bandyopadhyay, B., Li, G., Yin, H., and Kuret, J. (2007). Tau aggregation and toxicity in a cell culture model of tauopathy. J. Biol. Chem. 282, 16454-16464. doi: 10.1074/jbc.M700192200
4. Binder, L. I., Frankfurter, A., and Rebhun, L. I. (1985). The distribution of tau in the mammalian central nervous system. J. Cell Biol. 101, 1371-1378. doi: 10.1083/jcb.101.4.1371
5. Bing, G., Nguyen, X. V., Liu, M., Markesbery, W. R., and Sun, A. (2006). Biophysical and biochemical characterization of the intrinsic fluorescence from neurofibrillary tangles. Neurobiol. Aging 27, 823-830. doi: 10.1016/j.neurobiolaging.2005.04.005
6. Bloom, G. S. (2014). Amyloid-beta and tau: the trigger and bullet in Alzheimer disease pathogenesis. JAMA Neurol. 71, 505-508. doi: 10.1001/jamaneurol.2013.5847
7. Bugiani, O., Murrell, J. R., Giaccone, G., Hasegawa, M., Ghigo, G., Tabaton, M., et al. (1999). Frontotemporal dementia and corticobasal degeneration in a family with a P301S mutation in tau. J. Neuropathol. Exp. Neurol. 58, 667-677. doi: 10.1097/00005072-199906000-00011
8. Charlesworth, G., Gandhi, S., Bras, J. M., Barker, R. A., Burn, D. J., Chinnery, P. F., et al. (2012). Tau acts as an independent genetic risk factor in pathologically proven PD. Neurobiol. Aging 33, e837-e811. doi: 10.1016/j.neurobiolaging.2011.11.001
9. Clarke, G., Collins, R. A., Leavitt, B. R., Andrews, D. F., Hayden, M. R., Lumsden, C. J., et al. (2000). A one-hit model of cell death in inherited neuronal degenerations. Nature 406, 195-199. doi: 10.1038/35018098
10. Clarke, G., and Lumsden, C. J. (2005). Scale-free neurodegeneration: cellular heterogeneity and the stretched exponential kinetics of cell death. J. Theor. Biol. 233, 515-525. doi: 10.1016/j.jtbi.2004.10.028
11. Clavaguera, F., Bolmont, T., Crowther, R. A., Abramowski, D., Frank, S., Probst, A., et al. (2009). Transmission and spreading of tauopathy in transgenic mouse brain. Nat. Cell Biol. 11, 909-913. doi: 10.1038/ncb1901
12. Cleveland, D. W., Hwo, S. Y., and Kirschner, M. W. (1977). Purification of tau, a microtubule-associated protein that induces assembly of microtubules from purified tubulin. J. Mol. Biol. 116, 207-225. doi: 10.1016/0022-2836(77)90213-3
13. Dekkers, M. P., and Barde, Y. A. (2013). Developmental biology. Programmed cell death in neuronal development. Science 340, 39-41. doi: 10.1126/science.1236152
14. Delobel, P., Lavenir, I., Fraser, G., Ingram, E., Holzer, M., Ghetti, B., et al. (2008). Analysis of tau phosphorylation and truncation in a mouse model of human tauopathy. Am. J. Pathol. 172, 123-131. doi: 10.2353/ajpath.2008.070627
15. Edwards, S. N., and Tolkovsky, A. M. (1994). Characterization of apoptosis in cultured rat sympathetic neurons after nerve growth factor withdrawal. J. Cell Biol. 124, 537-546. doi: 10.1083/jcb.124.4.537
16. Fatokun, A. A., Dawson, V. L., and Dawson, T. M. (2014). Parthanatos: mitochondrial-linked mechanisms and therapeutic opportunities. Br. J. Pharmacol. 171, 2000-2016. doi: 10.1111/bph.12416
17. Fatouros, C., Pir, G. J., Biernat, J., Koushika, S. P., Mandelkow, E., Mandelkow, E. M., et al. (2012). Inhibition of tau aggregation in a novel Caenorhabditis elegans model of tauopathy mitigates proteotoxicity. Hum. Mol. Genet. 21, 3587-3603. doi: 10.1093/hmg/dds190
18. Fernandez-Nogales, M., Cabrera, J. R., Santos-Galindo, M., Hoozemans, J. J., Ferrer, I., Rozemuller, A. J., et al. (2014). Huntington's disease is a four-repeat tauopathy with tau nuclear rods. Nat. Med. 20, 881-885. doi: 10.1038/nm.3617
19. Fox, L. M., William, C. M., Adamowicz, D. H., Pitstick, R., Carlson, G. A., Spires-Jones, T. L., et al. (2011). Soluble tau species, not neurofibrillary aggregates, disrupt neural system integration in a tau transgenic model. J. Neuropathol. Exp. Neurol. 70, 588-595. doi: 10.1097/NEN.0b013e318220a658
20. Gomez-Isla, T., Hollister, R., West, H., Mui, S., Growdon, J. H., Petersen, R. C., et al. (1997). Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease. Ann. Neurol. 41, 17-24. doi: 10.1002/ana.410410106
21. Green, D. R., and Victor, B. (2012). The pantheon of the fallen: why are there so many forms of cell death? Trends Cell Biol. 22, 555-556. doi: 10.1016/j.tcb.2012.08.008
22. Hong, M., Zhukareva, V., Vogelsberg-Ragaglia, V., Wszolek, Z., Reed, L., Miller, B. I., et al. (1998). Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17. Science 282, 1914-1917. doi: 10.1126/science.282.5395.1914
23. Jeganathan, S., Chinnathambi, S., Mandelkow, E. M., and Mandelkow, E. (2012). Conformations of microtubule-associated protein Tau mapped by fluorescence resonance energy transfer. Methods Mol. Biol. 849, 85-99. doi: 10.1007/978-1-61779-551-0_7
24. Jicha, G. A., Berenfeld, B., and Davies, P. (1999). Sequence requirements for formation of conformational variants of tau similar to those found in Alzheimer's disease. J. Neurosci. Res. 55, 713-723.
25. Jicha, G. A., Bowser, R., Kazam, I. G., and Davies, P. (1997). Alz-50 and MC-1, a new monoclonal antibody raised to paired helical filaments, recognize conformational epitopes on recombinant tau. J. Neurosci. Res. 48, 128-132.
26. Klingstedt, T., Shirani, H., Aslund, K. O., Cairns, N. J., Sigurdson, C. J., Goedert, M., et al. (2013). The structural basis for optimal performance of oligothiophene-based fluorescent amyloid ligands: conformational flexibility is essential for spectral assignment of a diversity of protein aggregates. Chemistry 19, 10179-10192. doi: 10.1002/chem.201301463
27. Kole, A. J., Annis, R. P., and Deshmukh, M. (2013). Mature neurons: equipped for survival. Cell Death Dis. 4, e689. doi: 10.1038/cddis.2013.220
28. Kuchibhotla, K. V., Wegmann, S., Kopeikina, K. J., Hawkes, J., Rudinskiy, N., Andermann, M. L., et al. (2014). Neurofibrillary tangle-bearing neurons are functionally integrated in cortical circuits in vivo. Proc. Natl. Acad. Sci. U.S.A. 111, 510-514. doi: 10.1073/pnas.1318807111
29. Lira-De Leon, K. I., Garcia-Gutierrez, P., Serratos, I. N., Palomera-Cardenas, M., Figueroa-Corona Mdel, P., Campos-Pena, V., et al. (2013). Molecular mechanism of tau aggregation induced by anionic and cationic dyes. J. Alzheimers Dis. 35, 319-334. doi: 10.3233/JAD-121765
30. Lossos, A., Reches, A., Gal, A., Newman, J. P., Soffer, D., Gomori, J. M., et al. (2003). Frontotemporal dementia and parkinsonism with the P301S tau gene mutation in a Jewish family. J. Neurol. 250, 733-740. doi: 10.1007/s00415-003-1074-4
31. Mandelkow, E. M., and Mandelkow, E. (2012). Biochemistry and cell biology of tau protein in neurofibrillary degeneration. Cold Spring Harb. Perspect. Med. 2:a006247. doi: 10.1101/cshperspect.a006247
32. Mellone, M., Kestoras, D., Andrews, M. R., Dassie, E., Crowther, R. A., Stokin, G. B., et al. (2013). Tau pathology is present in vivo and develops in vitro in sensory neurons from human P301S tau transgenic mice: a system for screening drugs against tauopathies. J. Neurosci. 33, 18175-18189. doi: 10.1523/JNEUROSCI.4933-12.2013
33. Mocanu, M. M., Nissen, A., Eckermann, K., Khlistunova, I., Biernat, J., Drexler, D., et al. (2008). The potential for beta-structure in the repeat domain of tau protein determines aggregation, synaptic decay, neuronal loss, and coassembly with endogenous Tau in inducible mouse models of tauopathy. J. Neurosci. 28, 737-748. doi: 10.1523/JNEUROSCI.2824-07.2008
34. Morsch, R., Simon, W., and Coleman, P. D. (1999). Neurons may live for decades with neurofibrillary tangles. J. Neuropathol. Exp. Neurol. 58, 188-197. doi: 10.1097/00005072-199902000-00008
35. Nilsson, K. P., Lindgren, M., and Hammarstrom, P. (2012). A pentameric luminescent-conjugated oligothiophene for optical imaging of in vitro-formed amyloid fibrils and protein aggregates in tissue sections. Methods Mol. Biol. 849, 425-434. doi: 10.1007/978-1-61779-551-0_29
36. Pooler, A. M., Polydoro, M., Wegmann, S., Nicholls, S. B., Spires-Jones, T. L., and Hyman, B. T. (2013). Propagation of tau pathology in Alzheimer's disease: identification of novel therapeutic targets. Alzheimers. Res. Ther. 5, 49. doi: 10.1186/alzrt214
37. Probst, A., Gotz, J., Wiederhold, K. H., Tolnay, M., Mistl, C., Jaton, A. L., et al. (2000). Axonopathy and amyotrophy in mice transgenic for human four-repeat tau protein. Acta Neuropathol. 99, 469-481. doi: 10.1007/s004010051148
38. Sigurdson, C. J., Nilsson, K. P., Hornemann, S., Manco, G., Polymenidou, M., Schwarz, P., et al. (2007). Prion strain discrimination using luminescent conjugated polymers. Nat. Methods 4, 1023-1030. doi: 10.1038/nmeth1131
39. Sperfeld, A. D., Collatz, M. B., Baier, H., Palmbach, M., Storch, A., Schwarz, J., et al. (1999). FTDP-17: an early-onset phenotype with parkinsonism and epileptic seizures caused by a novel mutation. Ann. Neurol. 46, 708-715.
40. Spillantini, M. G., and Goedert, M. (2013). Tau pathology and neurodegeneration. Lancet Neurol. 12, 609-622. doi: 10.1016/S1474-4422(13)70090-5
41. Spires, T. L., Orne, J. D., Santacruz, K., Pitstick, R., Carlson, G. A., Ashe, K. H., et al. (2006). Region-specific dissociation of neuronal loss and neurofibrillary pathology in a mouse model of tauopathy. Am. J. Pathol. 168, 1598-1607. doi: 10.2353/ajpath.2006.050840
42. Tomlinson, B. E., Blessed, G., and Roth, M. (1970). Observations on the brains of demented old people. J. Neurol. Sci. 11, 205-242. doi: 10.1016/0022-510X(70)90063-8
43. Velasco, A., Fraser, G., Delobel, P., Ghetti, B., Lavenir, I., and Goedert, M. (2008). Detection of filamentous tau inclusions by the fluorescent Congo red derivative FSB [(trans,trans)-1-fluoro-2,5-bis(3-hydroxycarbonyl-4-hydroxy)styrylbenzene]. FEBS Lett. 582, 901-906. doi: 10.1016/j.febslet.2008.02.025
44. Vuono, R., Winder-Rhodes, S., de Silva, R., Cisbani, G., Drouin-Quellet, J. REGISTRY Investigators of the European Huntington's Disease Network. et al. (2015). The role of tau in the pathological process and clinical expression of Huntington's disease. Brain. doi: 10.1093/brain/awv107. [Epub ahead of print].
45. Weaver, C. L., Espinoza, M., Kress, Y., and Davies, P. (2000). Conformational change as one of the earliest alterations of tau in Alzheimer's disease. Neurobiol. Aging 21, 719-727. doi: 10.1016/S0197-4580(00)00157-3
46. Wegenast-Braun, B. M., Skodras, A., Bayraktar, G., Mahler, J., Fritschi, S. K., Klingstedt, T., et al. (2012). Spectral discrimination of cerebral amyloid lesions after peripheral application of luminescent conjugated oligothiophenes. Am. J. Pathol. 181, 1953-1960. doi: 10.1016/j.ajpath.2012.08.031
47. Winder-Rhodes, S. E., Hampshire, A., Rowe, J. B., Peelle, J. E., Robbins, T. W., Owen, A. M., et al. (2015). Association between MAPT haplotype and memory function in patients with Parkinson's disease and healthy aging individuals. Neurobiol. Aging 36, 1519-1528. doi: 10.1016/j.neurobiolaging.2014.12.006
48. Yasuda, M., Yokoyama, K., Nakayasu, T., Nishimura, Y., Matsui, M., Yokoyama, T., et al. (2000). A Japanese patient with frontotemporal dementia parkinsonism by a tau P301S mutation. Neurology 55, 1224-1227. doi: 10.1212/WNL.55.8.1224